Tisotumab vedotin Completed Phase 2 Trials for Ovarian Cancer / Fallopian Tube Cancer / Peritoneal Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0028213 (Ovarian Cancer) DBCOND0028487 (Fallopian Tube Cancer) DBCOND0030195 (Peritoneal Cancer)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT03657043	A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)	Tisotumab vedotin (DB16732)